PROJECT_EGG: An Intracavitary Electrocardiographic System for Real-time Positioning Peripherally Inserted Central Catheter Tip

Sponsor
Yuan Ling (Other)
Overall Status
Completed
CT.gov ID
NCT02409589
Collaborator
(none)
1,007
8
2
7
125.9
17.9

Study Details

Study Description

Brief Summary

The purpose of this study is to compare a new intracavitary ECG guiding method for real-time positioning the tip of three-way valve type peripherally inserted central catheters versus conventional surface prediction length method in terms of single-time target rate.

Condition or Disease Intervention/Treatment Phase
  • Device: ECG
  • Procedure: Surface prediction length method
N/A

Detailed Description

The use of peripherally inserted central catheters (PICCs) has increased significantly for cancer patients receiving chemotherapy. For these patients, PICCs afford many advantages with regards to complications and treatment convenience.

Current practice utilizes the estimated length of the catheter from puncture site to the junction of superior vena cava / right atrium (SVC-RA) for guiding tip placement. Next the catheter tip placement was confirmed by radiographic imaging prior to use of the line for administration of chemotherapy medications. In this case, the catheter is often mal-positioned and requires adjustment and repeat radiographic imaging in order to ensure proper placement, ideally at the SVC-RA junction. These potentially additional procedures are time-consuming and also expose patients, nurses and physicians to radiations.

Intracavitary electrocardiogram with an electrode placed inside the catheter during insertion has shown identifiable changes in P-wave, which are sufficient to guide PICC tip placement. Moreover, less procedural time and radiation are expected.

This study aims to demonstrate if this intracavitary electrocardiogram guided method is superior to conventional surface prediction length method in terms of single-time target rate of correct tip placement. In addition, we would like to investigate symptomatic thrombosis incidence and its risk factors after three-valve PICC implanted among patients with malignant tumors; to clarify procedure time used and cost of the new intracavitary ECG guiding method and to explore the maximal P-wave amplitude of intracavity ECG real-time positioning technology and its predictive factors.

Study Design

Study Type:
Interventional
Actual Enrollment :
1007 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Randomized Open-labeled Multicenter Study to Assess a New Intracavitary Electrocardiographic Guiding Method for Real-time Positioning the Tip of Three-way Valve Type Peripherally Inserted Central Catheters (PROJECT_EGG)
Study Start Date :
Mar 1, 2015
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Oct 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: ECG-guided PICC Tip Placement

New intracavitary ECG guiding method

Device: ECG
The ECG-guided PICC tip detection method will be used to identify catheter tip location during the procedural placement of the catheter. This method involves an ECG monitor which will be connected to the guidewire used for catheter placement. The changes in the ECG p-wave will guide correct PICC placement. An X-ray radiograph will be conducted to confirm the tip location after PICC placement.

Active Comparator: Conventional

Surface prediction length method

Procedure: Surface prediction length method
The method will estimate the length of the catheter from puncture site to the junction of superior vena cava / right atrium (SVC-RA) . Tip location is placed according to the estimated length but later on will be determinated by chest X-ray performed after the placement procedure. If the tip location is not at an ideal place, additional procedures and X-ray radiograph would be required in order to ensure proper tip location.

Outcome Measures

Primary Outcome Measures

  1. Single-time target rate [Less than 24 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients with malignant tumors who will require periodical infusion of chemotherapy drugs using three-valve PICC;

  2. Aged >18 to < 80 years old;

  3. Baseline ECG records prior to PICC catheter showed normal P wave;

  4. Agreed to participate in this study, and signed PICC informed consent.

Exclusion Criteria:
  1. Patients with heart diseases, such as valvular heart disease, atrial fibrillation, supraventricular tachycardia, pulmonary heart disease or having a pacemaker and post cardiac surgery which may affect P waves.

  2. Patients unable to lie in the prostrate or semi-supine position.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jiangsu Cancer Hospital Nanjing Jiangsu China
2 Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School Nanjing Jiangsu China
3 Nanjing General Hospital of Nanjing Military Command Nanjing Jiangsu China
4 Nanjing Hospital Affiliated to Nanjing Medical University Nanjing Jiangsu China
5 The 2nd Affliated Hospital of Nanjing Medical University Nanjing Jiangsu China
6 The First Affiliated Hospital of Soochow University Suzhou Jiangsu China
7 The Second Affiliated Hospital of Soochow University Suzhou Jiangsu China
8 People's Hospital Affiliated to Jiangsu University Zhenjiang Jiangsu China

Sponsors and Collaborators

  • Yuan Ling

Investigators

  • Principal Investigator: Ling Yuan, Master, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yuan Ling, Associate Chief Nurse, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
ClinicalTrials.gov Identifier:
NCT02409589
Other Study ID Numbers:
  • 2015-001
First Posted:
Apr 7, 2015
Last Update Posted:
Apr 14, 2022
Last Verified:
Apr 1, 2022

Study Results

No Results Posted as of Apr 14, 2022